Generic Lenalidomide

Lenalidomide (initially known as CC-5013 and marketed as RevlimidВ® by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes. [Wikipedia]

Lenalidomide Adverse Effects [FDA Report]

Lenalidomide side effect

  • CDC 501
  • CC-5013
  • IMiD3

Lenalidomide Chemical


Brand Names related Lenalidomide